Tjark Reblin

1.1k total citations
19 papers, 877 citations indexed

About

Tjark Reblin is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Tjark Reblin has authored 19 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cancer Research. Recurrent topics in Tjark Reblin's work include Lipoproteins and Cardiovascular Health (9 papers), Cancer, Lipids, and Metabolism (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Tjark Reblin is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Cancer, Lipids, and Metabolism (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Tjark Reblin collaborates with scholars based in Germany, United States and United Kingdom. Tjark Reblin's co-authors include Ulrike Beisiegel†, Axel Niendorf, Matthias Rath, Manfred Dietel, H.-J. Krebber, H. van Ahlen, Marcus Neureither, Aksam Yassin, Katrin Wolf and W. Küpper and has published in prestigious journals such as European Heart Journal, Journal of Lipid Research and American Journal of Kidney Diseases.

In The Last Decade

Tjark Reblin

17 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tjark Reblin Germany 13 500 268 215 169 139 19 877
Michael Stepanavage United States 11 905 1.8× 540 2.0× 254 1.2× 242 1.4× 72 0.5× 16 1.3k
S Marcovina United States 18 1.0k 2.0× 751 2.8× 383 1.8× 306 1.8× 118 0.8× 26 1.6k
Sarah Watson Sweden 9 286 0.6× 119 0.4× 118 0.5× 131 0.8× 91 0.7× 18 868
Blánaid Hicks United Kingdom 18 385 0.8× 202 0.8× 282 1.3× 161 1.0× 28 0.2× 41 1.1k
Úna C. McMenamin United Kingdom 23 449 0.9× 151 0.6× 333 1.5× 106 0.6× 53 0.4× 46 1.3k
L Giroux Canada 15 248 0.5× 99 0.4× 61 0.3× 148 0.9× 89 0.6× 31 829
Darryl J. Sleep United States 20 466 0.9× 404 1.5× 285 1.3× 88 0.5× 32 0.2× 46 1.4k
Claire Siemes Netherlands 13 169 0.3× 114 0.4× 135 0.6× 136 0.8× 39 0.3× 21 869
W. Mraz Germany 14 200 0.4× 273 1.0× 48 0.2× 85 0.5× 220 1.6× 24 1.0k
Damon A. Bell Australia 23 1.1k 2.2× 528 2.0× 300 1.4× 357 2.1× 66 0.5× 100 1.6k

Countries citing papers authored by Tjark Reblin

Since Specialization
Citations

This map shows the geographic impact of Tjark Reblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tjark Reblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tjark Reblin more than expected).

Fields of papers citing papers by Tjark Reblin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tjark Reblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tjark Reblin. The network helps show where Tjark Reblin may publish in the future.

Co-authorship network of co-authors of Tjark Reblin

This figure shows the co-authorship network connecting the top 25 collaborators of Tjark Reblin. A scholar is included among the top collaborators of Tjark Reblin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tjark Reblin. Tjark Reblin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ball, Greg, Tjark Reblin, J.R. Buchanan, et al.. (2019). A Framework for Safety Evaluation Throughout the Product Development Life-Cycle. Therapeutic Innovation & Regulatory Science. 54(4). 821–830. 8 indexed citations
2.
Powell, Gregory, Harry Seifert, Tjark Reblin, et al.. (2016). Social Media Listening for Routine Post-Marketing Safety Surveillance. Drug Safety. 39(5). 443–454. 66 indexed citations
3.
Rosak, C., Eberhard Standl, Tjark Reblin, Holger Stammer, & D. Seidel. (2006). Rosiglitazone is effective and well-tolerated in a range of therapeutic regimens during daily practice in patients with type 2 diabetes. International Journal of Clinical Practice. 60(9). 1040–1047. 7 indexed citations
4.
Ziegler, Dan, et al.. (2006). Efficacy and Safety of Flexible-Dose Vardenafil in Men with Type 1 Diabetes and Erectile Dysfunction. The Journal of Sexual Medicine. 3(5). 883–891. 57 indexed citations
5.
Rosak, C., R. Petzoldt, Robert Wolf, et al.. (2005). Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes. International Journal of Clinical Practice. 59(10). 1131–1136. 20 indexed citations
6.
Ahlen, H. van, Klaus W.J. Wahle, W. Küpper, et al.. (2005). Safety and Efficacy of Vardenafil, a Selective Phosphodiesterase 5 Inhibitor, in Patients with Erectile Dysfunction and Arterial Hypertension Treated with Multiple Antihypertensives. The Journal of Sexual Medicine. 2(6). 856–864. 69 indexed citations
7.
Reblin, Tjark, Jan Hinrich Bräsen, Hans Dieplinger, et al.. (2001). Renal handling of human apolipoprotein(a) and its fragments in the rat. American Journal of Kidney Diseases. 38(3). 619–630. 21 indexed citations
8.
Reblin, Tjark, et al.. (1999). Quantification of lipoprotein(a) and apolipoprotein(a) in plasma and lipoprotein fractions in the hypertriglyceridemic state. Atherosclerosis. 145(1). 71–79. 3 indexed citations
9.
Reblin, Tjark, et al.. (1998). Extrakorporale Giftelimination bei schwerer Salizylatintoxikation. Intensivmedizin und Notfallmedizin. 35(2). 132–136.
10.
Reblin, Tjark, Andreas Niemeier, Nicolette Meyer, et al.. (1997). 2.P.149 Uptake of lipoprotein(a) by mouse embryonic fibroblasts via the LDL-receptor and/or the LDL receptor-related protein. Atherosclerosis. 134(1-2). 147–147.
11.
Reblin, Tjark, Andreas Niemeier, Nicolette Meyer, et al.. (1997). Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. Journal of Lipid Research. 38(10). 2103–2110. 44 indexed citations
12.
Reblin, Tjark, et al.. (1995). Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosis. Coronary Artery Disease. 6(4). 347–350. 16 indexed citations
13.
Reblin, Tjark, Nicolette Meyer, Christine Labeur, Doris Henne‐Bruns, & Ulrike Beisiegel†. (1995). Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques. Atherosclerosis. 113(2). 179–188. 33 indexed citations
14.
Reblin, Tjark, Andreas Meyer, Helmut Albrecht, & H. Greten. (1994). Disseminated cryptococcosis in a patient with AIDS. Mycoses. 37(7-8). 275–279. 12 indexed citations
15.
Reblin, Tjark, Daniel J. Rader, Ulrike Beisiegel†, Heiner Greten, & H Bryan Brewer. (1992). Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma. Atherosclerosis. 94(2-3). 223–232. 35 indexed citations
16.
Beisiegel†, Ulrike, Axel Niendorf, Katrin Wolf, Tjark Reblin, & Matthias Rath. (1990). Lipoprotein(a) in the arterial wall. European Heart Journal. 11(suppl E). 174–183. 73 indexed citations
17.
Rath, Matthias, Axel Niendorf, Tjark Reblin, et al.. (1989). Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 9(5). 579–592. 385 indexed citations
18.
Huchzermeyer, H., I. Schmitz-Feuerhake, & Tjark Reblin. (1977). Determination of splenic blood flow by inhalation of radioactive rare gases. European Journal of Clinical Investigation. 7(5). 345–349. 19 indexed citations
19.
Schmitz-Feuerhake, I., H. Huchzermeyer, & Tjark Reblin. (1975). Determination of the specific blood flow of the liver by inhalation of radioactive rare gases.. PubMed. 22(3). 150–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Stepanavage Breakdown of academic impact, for papers by S Marcovina Breakdown of academic impact, for papers by Sarah Watson Breakdown of academic impact, for papers by Blánaid Hicks Breakdown of academic impact, for papers by Úna C. McMenamin Breakdown of academic impact, for papers by L Giroux Breakdown of academic impact, for papers by Darryl J. Sleep Breakdown of academic impact, for papers by Claire Siemes Breakdown of academic impact, for papers by W. Mraz Breakdown of academic impact, for papers by Damon A. Bell
Rankless by CCL
2026